miRNA and mRNA Signatures in Human Acute Kidney Injury Tissue

Acute kidney injury (AKI) is an important contributor to the development of chronic kidney disease (CKD). There is a need to understand molecular mediators that drive recovery and progression to CKD. In particular, the regulatory role of miRNAs in AKI is poorly understood. Herein, miRNA and mRNA seq...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of pathology Vol. 195; no. 1; pp. 102 - 114
Main Authors Janosevic, Danielle, De Luca, Thomas, Melo Ferreira, Ricardo, Gisch, Debora L., Cheng, Ying-Hua, Hato, Takashi, Luo, Jinghui, Yang, Yingbao, Hodgin, Jeffrey B., Phillips, Carrie L., Dagher, Pierre C., Eadon, Michael T.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acute kidney injury (AKI) is an important contributor to the development of chronic kidney disease (CKD). There is a need to understand molecular mediators that drive recovery and progression to CKD. In particular, the regulatory role of miRNAs in AKI is poorly understood. Herein, miRNA and mRNA sequencing were performed on biobanked human kidney tissues obtained during the routine care of subjects with a diagnosis of AKI, minimal change disease, or on nephrectomy tissue with no known kidney disease. mRNA analysis revealed that nephrectomy tissues exhibited an injury signature similar to that of AKI which was not identified in minimal change disease samples. The transcriptomic signature of human AKI was enriched in pathways involved in cell adhesion, epithelial-to-mesenchymal transition, and cell cycle arrest (eg, CDH6, ITGB6, CDKN1A). In AKI, up-regulation of miR-146a, miR-155, miR-142, and miR-122 was associated with pathways involved in immune cell recruitment, inflammation, and epithelial-to-mesenchymal transition. miR-122 and miR-146 were associated with down-regulation of DDR2 and IGFBP6, which are genes involved in the recovery and progression of kidney disease. These data provide integrated miRNA signatures that complement mRNA and other epigenetic data available in kidney atlases. [Display omitted]
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9440
1525-2191
1525-2191
DOI:10.1016/j.ajpath.2024.08.013